Zhende Medical (China) Performance
603301 Stock | 22.66 0.02 0.09% |
On a scale of 0 to 100, Zhende Medical holds a performance score of 7. The firm maintains a market beta of -0.18, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Zhende Medical are expected to decrease at a much lower rate. During the bear market, Zhende Medical is likely to outperform the market. Please check Zhende Medical's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether Zhende Medical's historical returns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Zhende Medical Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zhende Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Payout Ratio 1.6447 | Last Split Factor 1.4:1 | Ex Dividend Date 2024-07-03 | Last Split Date 2020-06-08 |
Begin Period Cash Flow | 2.1 B |
Zhende |
Zhende Medical Relative Risk vs. Return Landscape
If you would invest 2,024 in Zhende Medical Co on September 24, 2024 and sell it today you would earn a total of 242.00 from holding Zhende Medical Co or generate 11.96% return on investment over 90 days. Zhende Medical Co is generating 0.2163% of daily returns and assumes 2.3744% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than Zhende, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Zhende Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zhende Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zhende Medical Co, and traders can use it to determine the average amount a Zhende Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0911
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 603301 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.37 actual daily | 21 79% of assets are more volatile |
Expected Return
0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Zhende Medical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zhende Medical by adding it to a well-diversified portfolio.
Zhende Medical Fundamentals Growth
Zhende Stock prices reflect investors' perceptions of the future prospects and financial health of Zhende Medical, and Zhende Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zhende Stock performance.
Return On Equity | 0.0385 | ||||
Return On Asset | 0.0156 | ||||
Profit Margin | 0.05 % | ||||
Operating Margin | 0.13 % | ||||
Current Valuation | 5.9 B | ||||
Shares Outstanding | 266.45 M | ||||
Price To Book | 1.08 X | ||||
Price To Sales | 1.48 X | ||||
Revenue | 4.13 B | ||||
Gross Profit | 1.74 B | ||||
EBITDA | 462.31 M | ||||
Net Income | 198.4 M | ||||
Total Debt | 220.14 M | ||||
Book Value Per Share | 20.96 X | ||||
Cash Flow From Operations | 452.11 M | ||||
Earnings Per Share | 0.76 X | ||||
Total Asset | 7.27 B | ||||
Retained Earnings | 3.14 B | ||||
About Zhende Medical Performance
By analyzing Zhende Medical's fundamental ratios, stakeholders can gain valuable insights into Zhende Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zhende Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zhende Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Zhende Medical is entity of China. It is traded as Stock on SHG exchange.Things to note about Zhende Medical performance evaluation
Checking the ongoing alerts about Zhende Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zhende Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.About 60.0% of the company shares are owned by insiders or employees |
- Analyzing Zhende Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zhende Medical's stock is overvalued or undervalued compared to its peers.
- Examining Zhende Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zhende Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zhende Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zhende Medical's stock. These opinions can provide insight into Zhende Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zhende Stock analysis
When running Zhende Medical's price analysis, check to measure Zhende Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhende Medical is operating at the current time. Most of Zhende Medical's value examination focuses on studying past and present price action to predict the probability of Zhende Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhende Medical's price. Additionally, you may evaluate how the addition of Zhende Medical to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |